Diagnosis and treatment of antibody mediated rejection in lung transplantation: A retrospective case series

Transplant Immunology

Volumn 28, Issue 1, 2013, Pages 1-5

  Daoud, Ahmed H Sulieman ^a   Betensley, Alan D ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Acute allograft rejection; Antibody mediated rejection; Donor specific antibody; Lung transplantation

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D; DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; IMMUNOGLOBULIN; RITUXIMAB; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CAPILLARITIS; COMPLEMENT DEPOSITION; CONCURRENT INFECTION; DIFFUSE ALVEOLAR DAMAGE; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT DYSFUNCTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LUNG DISEASE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY;

ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIGENS; LUNG TRANSPLANTATION; MALE; PEPTIDE FRAGMENTS; PLASMAPHERESIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84873060020     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.11.009     Document Type: Article

References (22)

1. Jordan S.C., Reinsmoen N., Peng A., et al. Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol 2010, 25:2035-2045. [quiz 45-8].
2. Takemoto S.K., Zeevi A., Feng S., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004, 4:1033-1041.
3. Astor T.L., Weill D., Cool C., Teitelbaum I., Schwarz M.I., Zamora M.R. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant 2005, 24:2091-2097.
4. Astor T.L., Galantowicz M., Phillips A., Palafox J., Baker P. Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation. Am J Transplant 2009, 9:409-412.
5. Badesch D.B., Zamora M., Fullerton D., et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant 1998, 17:415-422.
6. Stewart S., Fishbein M.C., Snell G.I., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007, 26:1229-1242.
7. Magro C.M., Deng A., Pope-Harman A., et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation 2002, 74:1273-1280.
8. Parambil J.G., Myers J.L., Aubry M.C., Ryu J.H. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 2007, 132:50-57.
9. Poduval R.D., Kadambi P.V., Josephson M.A., et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation 2005, 79:228-235.
10. Colvin R.B. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007, 18:1046-1056.
11. Golocheikine A., Nath D.S., Basha H.I., et al. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant 2010, 29:410-416.
12. Wallace W.D., Reed E.F., Ross D., Lassman C.R., Fishbein M.C. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant 2005, 24:1565-1570.
13. Cusick M.F., Libbey J.E., Fujinami R.S. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 2011.
14. Goldfarb N.S., Avery R.K., Goormastic M., et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001, 71:242-246.
15. Magro C.M., Wusirika R., Frambach G.E., Nuovo G.J., Ferri C., Ross P. Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases. Appl Immunohistochem Mol Morphol 2006, 14:208-216.
16. Hachem R.R., Yusen R.D., Meyers B.F., et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 2010, 29:973-980.
17. Magro C.M., Klinger D.M., Adams P.W., et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant 2003, 3:1264-1272.
18. Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation 2008, 86:1019-1025.
19. Yousem S.A., Zeevi A. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies. Am J Surg Pathol 2012, 36:987-992.
20. Bartel G., Schwaiger E., Bohmig G.A. Prevention and treatment of alloantibody-mediated kidney transplant rejection. Transpl Int 2011, 24:1142-1155.
21. Hadjinicolaou A.V., Nisar M.K., Parfrey H., Chilvers E.R., Ostor A.J. Non-infectious pulmonary toxicity of rituximab: a systematic review. Rheumatology (Oxford) 2011.
22. Burton C., Kaczmarski R., Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003, 348:2690-2691.